ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Cardiac SPECT With Rotating Slant Hole Collimator

This study is currently recruiting participants.
Verified by Johns Hopkins University, January 2007

Sponsors and Collaborators: Johns Hopkins University
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Information provided by: Johns Hopkins University
ClinicalTrials.gov Identifier: NCT00328315
  Purpose

The goal is to conduct a clinical pilot study to evaluate the use of a rotating multi-segment slant-hole collimator in the detection of myocardial defects.


Condition
Coronary Artery Diseases
Chest Pain

MedlinePlus related topics:   Chest Pain    Coronary Artery Disease   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Screening, Longitudinal, Defined Population, Prospective Study

Further study details as provided by Johns Hopkins University:

Estimated Enrollment:   60
Study Start Date:   October 2006

Detailed Description:

Myocardial perfusion SPECT is recognized as an effective clinical diagnostic imaging technique in the assessment of myocardial perfusion and coronary artery diseases. It is the most important clinical application of SPECT imaging techniques.

The goal is to conduct a clinical pilot study to evaluate the use of RMSSH SPECT in the detection of myocardial defects especially in very sick patients in the nuclear medicine clinics, emergence room, and intensive care units. Comparison of the clinical utilities of the cardiac RMSSH SPECT technique with conventional cardiac planar and SPECT with parallel-hole collimation will also allow us to evaluate the potential application of the technique to a wider patient population.

The objective of this study is to test the hypothesis that quantitative 99mTc myocardial perfusion RMSSH SPECT provides similar diagnostic accuracy in patients with cardiac diseases as conventional SPECT imaging techniques.

  Eligibility
Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Males and Females 18-80 who are scheduled for a clinical Cardiac Stress Test

Exclusion Criteria:

  • Pregnant Women and Children
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00328315

Contacts
Contact: Linda Wilkins, RT, CCRP     410-955-8216     lwilkins@jhmi.edu    

Locations
United States, Maryland
Johns Hopkins Outpatient Center     Recruiting
      Baltimore, Maryland, United States, 21287
      Contact: Linda Wilkins, RT, CCRP     410-955-8216        

Sponsors and Collaborators
Johns Hopkins University
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Investigators
Principal Investigator:     Benjamin Tsui, Ph.D.     Johns Hopkins University    
  More Information


Study ID Numbers:   R01 EB 0019-83
First Received:   May 18, 2006
Last Updated:   January 3, 2007
ClinicalTrials.gov Identifier:   NCT00328315
Health Authority:   United States: Institutional Review Board

Keywords provided by Johns Hopkins University:
Myocardial Perfusion SPECT  

Study placed in the following topic categories:
Arterial Occlusive Diseases
Coronary Disease
Signs and Symptoms
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Pain
Arteriosclerosis
Ischemia
Coronary Artery Disease
Chest Pain

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 07, 2008




Links to all studies - primarily for crawlers